Cellular and Neuronal Aspects in Aortic Stenosis by J. Ker & WFP Van Heerden
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Cellular and Neuronal Aspects 
in Aortic Stenosis 
J. Ker1 and WFP Van Heerden2  
1Physician, University of Pretoria, Pretoria, 
2Pathologist, University of Pretoria, Pretoria, 
South Africa 
1. Introduction 
For quite some time the physiological approach to cardiac valve function held the belief that 
these are purely passive structures merely moving in response to changes in transvalvular 
pressure generated by atrial and ventricular contractions 1, 2, 3.  Today, this “passive 
hypothesis” is being challenged as numerous studies have shown that mammalian cardiac 
valves are capable of independent contraction during various stages of the cardiac cycle 1, 4, 
5. In order to understand this concept and the pathophysiological implications for valvular 
disorders one would need to understand the cellular components and appreciate the neural 
network innervating the diverse cellular milieu of the cardiac valve as we understand it 
today. 
The diverse cellular population of the aortic valve, together with its neuronal network will 
be discussed in order to clarify the cellular and neuronal aspects of the complex and still 
incompletely understood process of aortic stenosis. 
2. Macro structure of the aortic valve 
As a unit, the aortic valve is composed of four parts: the aortic annulus, the aortic valvular 
cusps, the sinuses of Valsalva and the sinotubular junction 3. The three semi-lunar cusps are 
attached at their base to a crown-shaped annulus 3. The interaction between the cusps and 
the root is extremely important to ensure adequate coronary blood flow. Proper closure of 
the cusps in diastole helps to preserve the shape of the aortic root and this ensures the 
creation of vortices of blood flow in the sinuses of Valsalva which is a major determinant of 
coronary blood flow 3. 
The aortic cusps are composed of three layers: the fibrosa, the spongiosa and the 
ventricularis 3. The fibrosa lines the aortic side and is rich in collagen fibers, whereas the 
ventricularis lines the ventricular side and is rich in elastin fibers 3, 6. The spongiosa lies 
between these two layers and is composed primarily of proteoglycans 3, 6. 
3. Cellular components of the aortic cusps 
Both sides of the aortic valve cusps, the fibrosa and ventricularis, are lined by endothelial 
cells 1, 2, 3. These valvular endothelial cells are able to respond to stress placed on the cusps, 
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particularly shear stress and can produce several vasoactive mediators, such as nitric oxide, 
endothelins and prostaglandins 1, 7, 8, thus translating mechanical stimuli into biological 
responses, referred to as mechanotransduction 3. The actual release of these various 
vasoactive mediators can be effected by neurotransmitters such as acetylcholine and 
substance P, released by nerve endings innervating the valvular cusps 7, 8. These substances 
released by the endothelium can in turn stimulate the local nerve terminals and elicit 
various reflex responses 1, 9. The role of this “endothelium-cusp-nerve interaction” in health 
and disease is an interesting and yet insufficiently explained arena in the healthy and 
diseased aortic valve. 
Below the layer of endothelial cells lining the outer and inner layer of the aortic cusps (the 
fibrosa and ventricularis), the extracellular matrix is found, composed of elastin, collagen 
and proteoglycans 10. In addition to the elastin, collagen and proteoglycans in this 
extracellular matrix, a population of valve interstitial cells can be found 2, 3. These consist of 
fibroblasts, smooth muscle cells and myofibroblasts 2, 3, 11. The proportion of these different 
cells comprising the interstitial cell component will depend on the condition and state of 
health of the valve 2. These cells possess important secretory and proliferative properties to 
repair and maintain the extracellular matrix 2, 3. They also have contractile properties and 
express the same structural genes as cardiac muscle, such as cardiac troponin T, I and C, 
cardiac myosin light chain and beta myosin heavy chain 2, 12. Immunohistological studies 
have shown that almost 60% of aortic valve interstitial cells can express alpha-smooth 
muscle actin 2, 13.  
The most recently identified cell type in the aortic valve is a population of resident stem cells 
which lie within the cusps 3, 14. These cells are hematopoietic in origin with later 
mobilization towards the valve cusps 15. 
The human aortic valve is an avascular structure, but is innervated by a network of afferent 
and efferent nerves 3. 
4. The aortic neural network 
The neural innervation of the aortic valve arise from two sources, the ventricular 
endocardial plexus 1 and the aortic adventitial wall 16. These nerves are found in the entire 
leaflet, except at the coapting edge 1. Compared to the two coronary leaflets, the 
noncoronary leaflet displays an attenuated density of innervation and the density of 
innervation declines in all the leaflets with advancing age 1. This decline in valvular neural 
innervation with age seems to be limited to the aortic valve 1. It seems that each cardiac 
valve is independently innervated with no nerve fibers extending between valves 2 . The 
thin aortic nerves display a circumferential pattern within each leaflet 2, 17. Morphologically 
and neurochemically these valvular nerve endings appear similar to the nerve endings 
found in the epicardium and endocardium of the human heart 1, 18. Aortic nerve terminals 
has been found to express immunoreactivity for tyrosine hydroxylase, neuropeptide Y, 
acetylcholinesterase, substance P and vasoactive intestinal peptide (VIP) 1, 2, 19 . These 
various neurotransmitters also have neuromodulatory effects, regulating the activity of 
several populations of neurons in the valve 2.  
Thus, it is clear that there exists a rich cellular milieu inside the cusps of the aortic valve, 
with a rich supply of nerve endings, each one releasing neurotransmitters with diverse 
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Fig. 1. S-100 staining of a stenotic valve shows the presence of positive spindle shaped cells 
suggestive of Schwann cells (arrows). (original magnification X 100). 
physiological effects, effecting a complex array of contractile, secretory and homeostatic 
actions 2.  (Fig. 1). The aortic valve can thus be seen as a structure that is regulated by a local 
neural network very similar to the gastrointestinal tract, bronchial tree and blood vessels 2 . 
5. Diverse cellular changes in aortic stenosis 
A cell not seen in the normal aortic valve is the osteoblast. However, during the 
inflammatory process leading to ultimate aortic stenosis, aortic valve myofibroblasts may 
differentiate into osteoblasts and thus contribute towards valve calcification 20. (Fig 2).  
Normal aortic valves are avascular and the oxygen demand of the cellular milieu is supplied 
by diffusion 21. However, in the stenotic aortic valve a vascularization process is part of the 
pathogenesis of aortic stenosis 22. (Fig 3). 
The presence of myofibroblasts is associated with expression of alpha smooth muscle actin 
and osteoblastic markers such as osteocalcin and bone sialoprotein 23. This contributes to 
fibrosis of the leaflets and the formation of calcified nodules 23. Distinction between smooth 
muscle cells and myofibroblasts is difficult as both cell types express alpha-smooth muscle 
actin. It is possible to distinguish between these two groups of cells with h-caldesmon 
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Fig. 2. Low power photomicrograph of a stenotic aortic valve shows the presence of 
calcifications (arrows) on the aortic side (a) of the valve (original magnification X40). 
immunohistochemical evaluation. H-caldesmon is specific for smooth muscle cells and do 
not react with myofibroblasts 24. (Figs 4 & 5).  
6. Possible future therapeutic implications of cellular and neuronal aspects 
of aortic stenosis 
From the preceding discussion it is clear that there are numerous possibilities for the 
development of new therapeutic agents in order to arrest the progression of the complex 
process of aortic stenosis. In the early stages the increase in smooth muscle cells and 
myofibroblasts may be inhibited by yet to be discovered inhibitors of differentiation. 
The process of angiogenesis in the valve leaflet may be blocked, as well as the differentiation 
of valvular myofibroblasts into osteoblasts with subsequent calcification. 
It is also possible that the still incompletely understood effects of neuronal stimulation of the 
valvular interstitial cells may play a causal role in the initial process of aortic stenosis and that 
these neurons may lend themselves susceptible to future inhibition by therapeutic agents. 
Lastly, the possible therapeutic role of native stem cells inside the valvular cusps are endless 
and only the future will tell. 
In conclusion, it can be said that the possible future therapy of the process of aortic stenosis 
may become a purely medical one, with surgery limited to cases discovered in the end stage 
of this complex process. 
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Fig. 3. Small blood vessels (arrow) in a stenotic aortic valve. (original magnification X 100). 
Inset: Higher magnification of the blood vessels. (original magnification X 200). 
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Fig. 4. Immunohistochemical staining of a decalcified stenotic aortic valve with smooth 
muscle actin (SMA) shows the presence of numerous positive cells (smooth muscle cells and 
myofibroblasts) (arrow) on the ventricular side (v) of the valve. Fewer positive cells are 
present on the aortic side (a). (original magnification X 100). 
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Fig. 5. H-caldesmon immunohistochemical stain (specific for smooth muscle cells) of the 
same area as in Fig. 4 demonstrates the portion of SMA positive cells that are smooth muscle 
cells (arrow). The SMA positive cells that did not stain with h-caldesmon are 
myofibroblastic in nature. (original magnification X 100). 
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Currently, aortic stenosis (AS) is the most prevalent valvular disease in developed countries. Pathological and
molecular mechanisms of AS have been investigated in many aspects. And new therapeutic devices such as
transcatheter aortic valve implantation have been developed as a less invasive treatment for high-risk patients.
Due to advanced prevalent age of AS, further discovery and technology are required to treat elderly patients
for longer life expectancy. This book is an effort to present an up-to-date account of existing knowledge,
involving recent development in this field. Various opinion leaders described details of established knowledge
or newly recognized advances associated with diagnosis, treatment and mechanism. Thus, this book will
enable close intercommunication to another field and collaboration technology for new devices. We hope that it
will be an important source, not only for clinicians, but also for general practitioners, contributing to
development of better therapeutic adjuncts in the future.
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